The FluidFM BOT Bio Series is the only instrument capable of measuring drug dose-response curves at a single-cell level, without the interference of a specifically designed delivery method. Researchers can now decouple drug response from side-effects caused by the delivery method, simplifying and optimizing the drug development process.
Using MRI to Diagnose Autism Spectrum Disorder
Using Microparticles to Repair and Detox Cardiac Muscle
How are Probiotic Formulations Validated?
Marburg Virus Structure and Transmission
Proteoforms in Drug Discovery
Manufacture and Composition of Micro-plates
Drinking green tea may benefit people with food allergies
Combining Improved Ion Usage Efficiency with Data Independent Acquisition to Quantify Proteomes
Effective porous plastic filters for respiratory devices
Total nucleic acid extraction for pathogen detection
World's largest map of protein connections holds clues to health and disease
Wyatt Technology Pioneers Multi-CQA Method for Gene Vectors
An Overview of GABA Receptor Pharmacology
An Overview of Dopamine Receptor Pharmacology
What is the Skin Microbiome?
Deliver any compound into any adherent cell - easy and precise solution for your drug assay
Accelerate Your PCR Setup to Combat COVID-19
Controlled Ice Nucleation in the Pharmaceutical Industry
Dr. Ben Collins
In this interview discover how combining Improved Ion Usage Efficiency with Data Independent Acquisition can help to Quantify Proteomes
Professor Carl Philpott
Professor Carl Philpott speaks to News-Medical about his research into smell loss as a potential early symptom for COVID-19.
Dr. Andrew Webb
Dr. Andrew Webb describes how his lab uses mass spectrometry-based techniques to understand the role of post-translational modifications in human disease.